Back
Royalty Pharma PLC Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
31
RPRX
Royalty Pharma PLC
Last Price:
28.50
Seasonality Move:
-7.4%
7 Day Trial
ALL ACCESS PASS
$
7
Master the Market: The Formula for a 96.3% Win Rate Revealed!
Act now!- The current trend is relatively stagnant and RPRX is experiencing slight selling pressure.
Royalty Pharma PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.14 | Buy |
| 20-day SMA: | 28.29 | Buy |
| 50-day SMA: | 29.38 | Sell |
| 200-day SMA: | 28.72 | Sell |
| 8-day EMA: | 28.22 | Buy |
| 20-day EMA: | 28.41 | Buy |
| 50-day EMA: | 28.87 | Sell |
| 200-day EMA: | 29.77 | Sell |
Royalty Pharma PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 47.99 | Sell |
| Chaikin Money Flow: | -300527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.78 - 29.16) | Sell |
| Bollinger Bands (100): | (27.94 - 30.08) | Sell |
Royalty Pharma PLC Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
- Royalty Pharma PLC share price is 28.41 while RPRX 8-day simple moving average is 28.14, which is a Buy signal.
- The stock price of RPRX is 28.41 while Royalty Pharma PLC 20-day SMA is 28.29, which makes it a Buy.
- Royalty Pharma PLC 50-day simple moving average is 29.38 while RPRX share price is 28.41, making it a Sell technically.
- RPRX stock price is 28.41 and Royalty Pharma PLC 200-day simple moving average is 28.72, creating a Sell signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
31
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a Sell
The current Royalty Pharma PLC [RPRX] share price is $28.41. The Score for RPRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
12.69B
Price in USD:
28.41
Share Volume:
2.04M
Royalty Pharma PLC 52-Week Range
52-Week High:
35.70
52-Week Low:
25.92
Sell
31
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?
The Royalty Pharma PLC stock price is 28.41 USD today. -
Will RPRX stock go up or go down?
Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators -
Is Royalty Pharma PLC overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
- Royalty Pharma PLC share price is 28.41 while RPRX 8-day exponential moving average is 28.22, which is a Buy signal.
- The stock price of RPRX is 28.41 while Royalty Pharma PLC 20-day EMA is 28.41, which makes it a Buy.
- Royalty Pharma PLC 50-day exponential moving average is 28.87 while RPRX share price is 28.41, making it a Sell technically.
- RPRX stock price is 28.41 and Royalty Pharma PLC 200-day simple moving average is 29.77, creating a Sell signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
- Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.32 per share, and an increase next year of $0.45 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
- RPRX Moving Average Covergence Divergence (MACD) indicator is -0.31, suggesting Royalty Pharma PLC is a Sell
- Royalty Pharma PLC Relative Strength Index (RSI) is 47.99, which suggest Royalty Pharma PLC is oversold
- The Bollinger Bands (25) for Royalty Pharma PLC is (27.78 - 29.16), which suggest Royalty Pharma PLC is a Sell
- The Bollinger Bands (100) for Royalty Pharma PLC is (27.94 - 30.08), which suggest Royalty Pharma PLC is a Sell
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.